Provider and Caregiver Connection: Addressing Patient Concerns While Managing Chemotherapy Induced Nausea and Vomiting
WebcastFaculty
OVERVIEW
Provider and Caregiver Connection: Addressing Patient Concerns While Managing Chemotherapy Induced Nausea and Vomiting is organized by Physicians Education Resource, LLC (PER) and will be held during Oct 31, 2017 - Oct 31, 2018.
The target audience for this medical event is directed toward oncologists, nurse practitioners, nurses, and physician assistants involved in the treatment and management of patients with cancer treatment-related symptoms. Pharmacists, researchers, fellows, and other healthcare professionals interested in the treatment of cancer may also participate. This CME Conference has been approved for a maximum of 2.00 AMA PRA Category 1 Credits.
Conference Overview :
Chemotherapy-induced nausea and vomiting (CINV) remains a significant concern for patients and care providers alike. The emergence of CINV has the potential to disrupt patient adherence to treatment protocols, reduce patient quality of life, and adversely influence other outcomes. In order to optimally manage patients who are receiving chemotherapy, clinicians need to be aware of recent changes in the classification of emetic risk with different therapy types, as well as advancements in the pharmacologic management of CINV. This educational activity has the dual objectives of updating healthcare providers on the latest advances in the management of CINV, as well as bringing greater attention to the patient perspective along the treatment continuum of care. This will be accomplished through a combination of didactic presentation (featuring audio clips of experts providing their perspectives on the state of the art in CINV management) and a patient panel discussion.
Conference Objectives :
At the conclusion of this activity, you should be better prepared to:
• Describe the impact and occurrence of CINV with commonly used chemotherapy regimens
• Discuss emerging clinical trial data and evidence-based recommendations on supportive care strategies as they apply to the management of CINV
• Apply clinical practice guidelines and a multidisciplinary approach to optimize the prevention and management of CINV in patients with solid tumors and hematologic malignancies
• Incorporate skills that promote effective communication and coordination of care regarding CINV between the provider and the patient/caregiver
Additional details will be posted as soon as they are available.
The target audience for this medical event is directed toward oncologists, nurse practitioners, nurses, and physician assistants involved in the treatment and management of patients with cancer treatment-related symptoms. Pharmacists, researchers, fellows, and other healthcare professionals interested in the treatment of cancer may also participate. This CME Conference has been approved for a maximum of 2.00 AMA PRA Category 1 Credits.
Conference Overview :
Chemotherapy-induced nausea and vomiting (CINV) remains a significant concern for patients and care providers alike. The emergence of CINV has the potential to disrupt patient adherence to treatment protocols, reduce patient quality of life, and adversely influence other outcomes. In order to optimally manage patients who are receiving chemotherapy, clinicians need to be aware of recent changes in the classification of emetic risk with different therapy types, as well as advancements in the pharmacologic management of CINV. This educational activity has the dual objectives of updating healthcare providers on the latest advances in the management of CINV, as well as bringing greater attention to the patient perspective along the treatment continuum of care. This will be accomplished through a combination of didactic presentation (featuring audio clips of experts providing their perspectives on the state of the art in CINV management) and a patient panel discussion.
Conference Objectives :
At the conclusion of this activity, you should be better prepared to:
• Describe the impact and occurrence of CINV with commonly used chemotherapy regimens
• Discuss emerging clinical trial data and evidence-based recommendations on supportive care strategies as they apply to the management of CINV
• Apply clinical practice guidelines and a multidisciplinary approach to optimize the prevention and management of CINV in patients with solid tumors and hematologic malignancies
• Incorporate skills that promote effective communication and coordination of care regarding CINV between the provider and the patient/caregiver
Additional details will be posted as soon as they are available.
SPECIALITIES
Oncology
Quick Links